XML 38 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Share Based Compensation Expense and Related Income Tax Benefit

The following table summarizes share-based compensation expense and the related income tax benefit recognized for the Company’s share-based compensation awards. Share-based compensation expenses are recorded within Selling, general and administrative in the Company’s Condensed Consolidated Statement of Operations.

 

 

Three Months Ended March 31,

 

($ in millions)

 

2024

 

 

2023

 

Share-based compensation expense

 

$

6.3

 

 

$

4.1

 

Income tax benefit

 

 

2.2

 

 

 

1.1

 

 

Schedule of Outstanding Performance Stock Units Activity, Restricted Stock Awards, Restricted Stock Units and Performance-based Stock Options

Activity for RSAs for the three months ended March 31, 2024 was as follows:

 

 

Class A Common Stock

 

 

Weighted Average Grant Date Fair Value

 

Unvested at December 31, 2023

 

 

3,550,365

 

 

$

9.26

 

Granted

 

 

1,832,799

 

 

 

7.97

 

Forfeited (1)

 

 

275,405

 

 

 

11.28

 

Vested

 

 

689,808

 

 

 

10.70

 

Unvested at March 31, 2024

 

 

4,417,951

 

 

$

8.38

 

 

 

 

 

 

 

 

Activity for RSUs for the three months ended March 31, 2024 was as follows:

 

 

 

Class A Common Stock

 

 

Weighted Average Grant Date Fair Value

 

Unvested at December 31, 2023

 

 

171,384

 

 

$

7.41

 

Granted

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

Vested

 

 

 

 

 

 

Unvested at March 31, 2024

 

 

171,384

 

 

$

7.41

 

 

 

 

 

 

 

 

Activity for PSUs for the three months ended March 31, 2024 was as follows:

 

 

 

Class A Common Stock (2)

 

 

Weighted Average Grant Date Fair Value

 

Unvested at December 31, 2023

 

 

1,482,791

 

 

$

10.88

 

Granted

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

Vested

 

 

 

 

 

 

Unvested at March 31, 2024

 

 

1,482,791

 

 

$

10.88

 

 

 

 

 

 

 

 

(1)
The forfeited shares include shares forfeited as a result of employee terminations and shares withheld to satisfy employees’ tax withholding and payment obligations in connection with the vesting of restricted stock awards under the Incentive Plan during the three months ended March 31, 2024; further, these forfeited shares are added back to the amount of shares available for grant under the Incentive Plan.
(2)
Represent shares to be paid out at 100% target level.

Activity for PSOs for the three months ended March 31, 2024 was as follows:

 

 

 

Options

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term (in years)

 

 

Aggregate Intrinsic Value

 

Outstanding at December 31, 2023

 

 

1,148,822

 

 

 

6.13

 

 

 

7.0

 

 

$

2,768,661

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2024

 

 

1,148,822

 

 

$

6.13

 

 

 

7.0

 

 

$

5,594,763

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options vested and exercisable at March 31, 2024

 

 

 

 

$

 

 

 

 

 

$

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Fair value was estimated on the date of grant using Monte Carlo simulation with the following weighted average assumptions:

 

 

 

Three Months Ended March 31, 2023

 

Risk-free interest rate

 

 

3.42

%

Expected volatility

 

 

52.82

%

Dividend yield

 

 

0

%

Expected term (in years)

 

 

4.5